journal article·2023-03-24Open access

Bio-Entities Based on Albumin Nanoparticles and Biomimetic Cell Membranes: Design, Characterization and Biophysical Evaluation

Marcela-Elisabeta Barbinta-Patrascu, Sorina Iftimie, Nicoleta Cazacu, Diana Lavinia Stan, Andreea Costas, Adriana Elena Balan, Claudia Gabriela Chilom

Coatings· Volume 13· Issue 4

Abstract

Protein-based particles are one of the most important research topics in nanomedicine, being used especially as drug delivery systems. From the wide variety of proteins, albumins offer several advantages in biomedical applications due to their special properties. Albumin nanoparticles play an important role as carriers in the drug delivery of chemical and biomolecular drugs, such as anticancer drugs; offer many advantages, such as biocompatibility and biodegradability; and are well-tolerated, without any side effects. In this work, various types of bovine serum albumin nanoparticles (BSA NPs), with or without ascorbic acid or glucose, were prepared via different nanoprecipitation methods. The obtained BSA NPs were characterized by UV–Vis absorption spectroscopy. Their size and morphology were studied by Scanning Electron Microscopy (SEM) and Atomic Force Microscopy (AFM). The stability in time of the developed BSA NPs was spectrally monitored. Three types of bio-entities containing BSA NPs and chlorophyll-labeled artificial cell membranes were “green” developed. The designed biohybrids were characterized by UV–Vis absorption and fluorescence emission spectroscopy, and their three-dimensional topography was investigated by AFM. Both the size and shape of the developed bio-entities were monitored through SEM analysis. These results could be exploited in the development of novel drug carrier systems or as bio-coatings to be used in the biomedical field.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Protein Interaction Studies and Fluorescence Analysis · Nanoparticle-Based Drug Delivery · Pickering emulsions and particle stabilization

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Faculty of Physics, University of Bucharest, 405 Atomistilor Street, P.O. Box MG-11, 077125 Magurele, Romania

National Institute of Materials Physics, 077125 Magurele, Romania

Funding

Romanian Ministry of Research, Innovation and Digitization

References (67)

Show source-provided references
1. The Role of Albumin in Fluid and Electrolyte Balance10.1097/00129804-200609000-00004 ↗
2. Albumin and mammalian cell culture: Implications for biotechnology applications10.1007/s10616-010-9263-3 ↗
3. How human serum albumin-selective DNA aptamer binds to bovine and canine serum albumins10.1002/bip.23421 ↗
4. Albumin conjugates and assemblies as versatile bio-functional additives and carriers for biomedical applications10.1039/C8TB02477D ↗
5. Characterisation by fluorescence of human and bovine serum albumins in interaction with eosin Y
6. A spectroscopic study of the interaction of HSA with tetracaine
7. Spectroscopic Insights on the Binding of Rutin to Bovine Serum Albumin
8. Native albumin for targeted drug delivery10.1517/17425247.2010.498474 ↗
9. Chilom, C.G., Bălan, A., Sandu, N., Bălăşoiu, M., Stolyar, S., and Orelovich, O. (2020). Exploring the Conformation and Thermal Stability of Human Serum Albumin Corona of Ferrihydrite Nanoparticles. Int. J. Mol. Sci., 21.10.3390/ijms21249734 ↗
10. A spectroscopic approach of pH effect on thermal denaturation of human and bovine serum albumins
11. Electrostatic Unfolding and Interactions of Albumin Driven by pH Changes: A Molecular Dynamics Study10.1021/jp409936v ↗
12. Dendrimers Bind Human Serum Albumin10.1021/jp9011119 ↗
13. Taguchi, K., Okamoto, Y., Matsumoto, K., Otagiri, M., and Chuang, V. (2021). When Albumin Meets Liposomes: A Feasible Drug Carrier for Biomedical Applications. Pharmaceuticals, 14.10.3390/ph14040296 ↗
14. The Uniqueness of Albumin as a Carrier in Nanodrug Delivery10.1021/acs.molpharmaceut.1c00046 ↗
15. Adsorption of human serum albumin on functionalized single-walled carbon nanotubes reduced cytotoxicity10.1016/j.cbi.2018.03.015 ↗
16. Colloidal quantum dots conjugated with human serum albumin-interactions and bioimaging properties10.1016/j.opelre.2017.04.004 ↗
17. Albumin nanostructures as advanced drug delivery systems10.1080/17425247.2016.1193149 ↗
18. Ferrihydrite nanopar-ticles interaction with model lipid membranes10.1016/j.chemphyslip.2019.104851 ↗
19. Wu, J. (2021). The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application. J. Pers. Med., 11.10.3390/jpm11080771 ↗
20. Chubarov, A.S. (2022). Serum Albumin for Magnetic Nanoparticles Coating. Magnetochemistry, 8.10.3390/magnetochemistry8020013 ↗
21. Comparison of Different Crosslinking Methods for Preparation of Docetaxel-loaded Albumin Nanoparticles
22. Hong, S., Choi, D.W., Kim, H.N., Park, C.G., Lee, W., and Park, H.H. (2020). Protein-Based Nanoparticles as Drug Delivery Systems. Pharmaceutics, 12.10.3390/pharmaceutics12070604 ↗
23. Bacteriogenic Platinum Nanoparticles for Applicationin Nanomedicine10.3389/fchem.2021.624344 ↗
24. Hornok, V. (2021). Serum Albumin Nanoparticles: Problems and Prospects. Polymers, 13.10.3390/polym13213759 ↗
25. A simple improved desolvation method for the rapid preparation of albumin nanoparticles10.1016/j.ijbiomac.2016.05.032 ↗
26. Chemical cross-linking in the structural analysis of protein assemblies10.1016/j.ymeth.2018.05.023 ↗
27. Genipin-crosslinked human serum albumin coating using a tannic acid layer for enhanced oral administration of curcumin in the treatment of ulcerative colitis10.1016/j.foodchem.2020.127241 ↗
28. Characteristic of ascorbic acid in crosslinked chitosan edible film as drug delivery system membrane10.1051/matecconf/201815401027 ↗
29. Citric acid: A green cross-linker of biomaterials for biomedical applications10.1016/j.eurpolymj.2021.110271 ↗
30. Barrier and mechanical properties of plasticized and cross-linked nanocellulose coatings for paper packaging applications10.1007/s10570-017-1405-8 ↗
31. Effect of different cross-linking agents on the preparation of bovine serum albumin nanoparticles10.1007/s13738-019-01850-9 ↗
32. Development of carboplatin loaded bovine serum albumin nanoparticles and evaluation of its effect on an ovarian cancer cell line10.1016/j.jddst.2021.102655 ↗
33. Strategies for Preparing Albumin-based Nanoparticles for Multifunctional Bioimaging and Drug Delivery10.7150/thno.19365 ↗
34. Cho, H., Jeon, S.I., Ahn, C.-H., Shim, M.K., and Kim, K. (2022). Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation. Pharmaceutics, 14.10.3390/pharmaceutics14040728 ↗
35. Multi-spectroscopic and molecular modeling approaches to elucidate the binding interaction between bovine serum albumin and darunavir, a HIV protease inhibitor10.1016/j.saa.2017.07.040 ↗
36. Molecular insights into binding mechanism of rutin to bovine serum albumin—Levothyroxine complex: Spectroscopic and molecular docking approaches10.1016/j.saa.2021.120261 ↗
37. Interaction of repaglinide with bovine serum albumin: Spectroscopic and molecular docking approaches10.1016/j.jpha.2019.03.007 ↗
38. Unraveling the mysteries of serum albumin-More than just a serum protein10.3389/fphys.2014.00299 ↗
39. Preparation of Drug-Loaded Albumin Nanoparticles and Its Application in Cancer Therapy10.1155/2022/3052175 ↗
40. Nanoparticle Albumin-Bound Anticancer Agents10.1007/978-3-319-16241-6_10 ↗
41. Tacheva, B., Paarvanova, B., Ivanov, I.T., Tenchov, B., Georgieva, R., and Karabaliev, M. (2018). Drug Exchange between Albumin Na-noparticles and Erythrocyte Membranes. Nanomaterials, 9.10.3390/nano9010047 ↗
42. Teixeira, S., Carvalho, M.A., and Castanheira, E.M.S. (2022). Functionalized Liposome and Albumin-Based Systems as Carriers for Poorly Water-Soluble Anticancer Drugs: An Updated Review. Biomedicines, 10.10.3390/biomedicines10020486 ↗
43. Enhanced biostability of nanoparticle-based drug delivery systems by albumin corona10.2217/nnm.14.86 ↗
44. Construction a Long-Circulating Delivery System of Liposomal Curcumin by Coating Albumin10.1021/acsomega.0c00930 ↗
45. Pasarin, D., Ghizdareanu, A.-I., Enascuta, C.E., Matei, C.B., Bilbie, C., Paraschiv-Palada, L., and Veres, P.-A. (2023). Coating Materials to Increase the Stability of Liposomes. Polymers, 15.10.3390/polym15030782 ↗
46. Liposome: Classification, preparation, and applications10.1186/1556-276X-8-102 ↗
47. Barbinta-Patrascu, M.-E., Gorshkova, Y., Ungureanu, C., Badea, N., Bokuchava, G., Lazea-Stoyanova, A., Bacalum, M., Zhi-gunov, A., and Petrovič, S.M. (2021). Characterization and Antitumoral Activity of Biohybrids Based on Turmeric and Silver/Silver Chloride Nanoparticles. Materials, 14.10.3390/ma14164726 ↗
48. Gorshkova, Y., Barbinta-Patrascu, M.-E., Bokuchava, G., Badea, N., Ungureanu, C., Lazea-Stoyanova, A., Răileanu, M., Bacalum, M., Turchenko, V., and Zhigunov, A. (2021). Biological Performances of Plasmonic Biohybrids Based on Phy-to-Silver/Silver Chloride Nanoparticles. Nanomaterials, 11.10.3390/nano11071811 ↗
49. Strain, H.H., Svec, W.A., Vernon, L.P., and Seely, G.R. (1966). The Chlorophylls, Academic Press.
50. Santos-Rebelo, A., Kumar, P., Pillay, V., Choonara, Y.E., Eleutério, C., Figueira, M., Viana, A.S., Ascensão, L., Molpeceres, J., and Rijo, P. (2019). Development and mechanistic insight into the enhanced cytotoxic potential of Parvifloron D albumin nanoparticles in EGFR-overexpressing pancreatic cancer cells. Cancers, 11.10.3390/cancers11111733 ↗
51. Sugar ligand-mediated drug delivery10.4155/fmc-2019-0114 ↗
52. Vitamin C and glucose cross-linked chitosan as a versatile platform for drug delivery
53. Supported phospholipid bilayers with chlorophyll for optoelectronic devices
54. Procaine effects on model membranes with chlorophyll a
55. Plant Stress Detection by Reflectance and Fluorescencea10.1111/j.1749-6632.1998.tb09002.x ↗
56. Synthetic nanoparticles of bovine serum albumin with en-trapped salicylic acid
57. Sezer, A.D. (2014). Liposomes as Potential Drug Carrier Systems for Drug Delivery, Application of Nanotechnology in Drug Delivery, IntechOpen.10.5772/57028 ↗
58. Tryptophan at Position 181 of the D2 Protein of Photo-system II Confers Quenching of Variable Fluorescence of Chlorophyll: Implications for the Mechanism of Energy-Dependent Quenching10.1021/bi9915622 ↗
59. Fluorescence and Docking Studies of the Interaction between Human Serum Albumin and Pheophytin10.3390/molecules201019526 ↗
60. Bypassing the RES: Physicochemical barriers to nanocarrier clearance
61. Enhanced therapeutic efficacy of a combination of doxorubicin and bovine serum albumin-conjugated nanoparticles for hepatocellular carcinoma
62. High resolution magnetic force microscopy of patterned L10-FePt dot arrays by nanosphere lithography10.1088/0957-4484/19/9/095703 ↗
63. Preparation and evaluation of bovine serum albumin nanoparticles for ex vivo colloidal stability in biological media10.1016/j.colsurfa.2015.04.017 ↗
64. Sustainable technologies for liposome preparation10.1016/j.supflu.2020.104984 ↗
65. Nanoparticles in Medicine: Therapeutic Applications and Developments10.1038/sj.clpt.6100400 ↗
66. Nanocarriers as an emerging platform for cancer therapy10.1038/nnano.2007.387 ↗
67. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance10.1016/j.jconrel.2009.01.021 ↗